Intercellular Adhesion Molecule-1

Name
Intercellular Adhesion Molecule-1
Accession Number
DBCAT001836
Description

Not Available

Drugs
DrugDrug Description
Sipuleucel-TAn autologous cellular immunotherapy indicated for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer.
Drugs & Drug Targets
DrugTargetType
Sipuleucel-TProstatic acid phosphatasetarget